Post Photorefractive Keratectomy (PRK) Use of an Eye Shield for Maintaining Vision and Mitigating Pain
Nexis-CS0032
Sponsor study identifier
interventional
30
1 country
1
Study Start
March 1, 2012
Actual (reported)Primary Completion
October 31, 2013
Actual (reported)Study Completion
October 31, 2013
Actual (reported)The purpose of this research is to determine if an investigational thin shield over the cornea can safely and effectively reduce or eliminate pain following Post Photorefractive Keratectomy (PRK). The thin shield is made of silicone. The materials used to make the corneal shield all have a history of use in medical devices, contact lenses, and/or corneal shields and have been used safely in the eye.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 31, 2013
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 1, 2012
Actual (reported)April 19, 2012
Actual (reported)May 7, 2012
Actual (reported)October 31, 2013
Actual (reported)October 31, 2013
Actual (reported)December 22, 2021
Actual (reported)Number of Participants With Pain Score of Four or Greater. Score Range: 0-10, Higher Score Corresponds to More Pain.
Day 30
Mean Change in Uncorrected Visual Acuity
Six months
Participants receive eye shield during PRK surgery
The thin shield is made of silicone. The materials used to make the corneal shield all have a history of use in medical devices, contact lenses, and/or corneal shields and have been used safely in the eye.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Byers Eye Institute at Stanford
Palo Alto, California, 94303, United States
Sales CS, Manche EE. Prospective evaluation of a novel silicone corneal shield after PRK: 6-month efficacy, safety, and predictability outcomes. Clin Ophthalmol. 2019 Jan 7;13:115-121. doi: 10.2147/OPTH.S183120. eCollection 2019.
Edward E Manche, MD
Stanford University
30 participants (actual enrollment reported by the registry).
First Submitted
April 19, 2012
First Posted
May 7, 2012
Study Start
March 1, 2012
Actual (reported)Effect of IV Lidocaine Infusions on Pain
Contact the study team to confirm eligibility.
Primary Completion
October 31, 2013
Actual (reported)Study Completion
October 31, 2013
Actual (reported)Last Updated
December 22, 2021
Results First Posted
December 22, 2021
Record last verified: 2021-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: